Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Nissan Set to Reject Honda Merger. The Stocks Diverge.
A combination of Honda and Nissan, which would have created the world’s third-largest auto maker, looks to be off the table.
eLife4d
Dissecting infant leukemia developmental origins with a hemogenic gastruloid model
This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...
Eurohoops.net4d
Carsen Edwards pushes Bayern to an overtime win versus ALBA Berlin
With action spilling into overtime, FC Bayern Munich creates a double-digit lead and beats fellow Turkish Airlines EuroLeague ...